[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100344489":3},{"organization":4,"outcomesModule":7,"designInfo":49,"detailedDescription":48,"studyPopulation":52,"armGroups":48,"interventions":48,"overallOfficials":53,"centralContacts":61,"locations":67,"responsibleParty":87,"collaborators":48,"id":89,"slug":48,"hasResults":90,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":48,"eligibilityCriteria":94,"healthyVolunteers":90,"sex":95,"minAge":96,"maxAge":48,"enrollmentInfo":97,"targetDuration":48,"studyType":100,"phases":48,"briefSummary":101,"conditions":102,"keywords":48,"overallStatus":70,"whyStopped":48,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":113},{"fullName":5,"class":6},"Grupo Espanol de Tumores Neuroendocrinos","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":22,"otherOutcomes":48},[9,13,16,19],{"measure":10,"description":11,"timeFrame":12},"Hystopathological characteristics of the tumor","Based on pathologist evaluation of biopsy including differentiated, medullar or anaplasic.","Baseline",{"measure":14,"description":15,"timeFrame":12},"Situation of the tumor at first-diagnosis","Local tumor, locoregional tumor or metastatic disease.",{"measure":17,"description":18,"timeFrame":12},"Tumor-Node-Metastasis classification","Based on the AJCC (American Joint Committee on Cancer) 2018 TNM system: T for extent or size of the tumor, N for lymph nodes spread and M for metastasis.",{"measure":20,"description":21,"timeFrame":12},"Tumor Stage","From I to IV, based on the interpretation of the TNM classification and depending on the hystopathological characteristics of the tumor.",[23,27,30,33,36,39,42,45],{"measure":24,"description":25,"timeFrame":26},"Patient situation at the end of treatment","Results of clinical evaluation of the disease including complete response, partial response, stable disease, progression of disease or death","12 months",{"measure":28,"description":29,"timeFrame":26},"Number of patients with BRAF mutation","Total patients with available results on BRAF status and proportion of patients with mutated BRAF or native BRAF.",{"measure":31,"description":32,"timeFrame":26},"Number of patients with RET mutation","Total patients with available results on RET status and proportion of patients with mutated RET or native RET.",{"measure":34,"description":35,"timeFrame":26},"Number of patients with PI3K mutation","Total patients with available results on PI3K status and proportion of patients with mutated PI3K or native PI3K.",{"measure":37,"description":38,"timeFrame":26},"Number of patients with RAS mutation","Total patients with available results on RAS status and proportion of patients with mutated RAS or native RAS.",{"measure":40,"description":41,"timeFrame":26},"Number of patients with PAX8\u002FPAR mutation","Total patients with available results on PAX8\u002FPAR status and proportion of patients with mutated PAX8\u002FPAR or native PAX8\u002FPAR.",{"measure":43,"description":44,"timeFrame":26},"Number of patients with P53 mutation","Total patients with available results on P53 status and proportion of patients with mutated P53 or native P53.",{"measure":46,"description":47,"timeFrame":26},"Number of patients with PTEN mutation","Total patients with available results on PTEN status and proportion of patients with mutated PTEN or native PTEN.",null,{"allocation":48,"interventionModel":48,"interventionModelDescription":48,"primaryPurpose":48,"observationalModel":50,"timePerspective":51,"maskingInfo":48},"ECOLOGIC_OR_COMMUNITY","CROSS_SECTIONAL","Patients ≥ 18 years visited in the oncology services of the participating centers that have a diagnosis of primary cancer located in the thyroid gland.",[54,58],{"name":55,"affiliation":56,"role":57},"Jorge Hernando Cubero, M.D.","Hospital Universitari Vall d'Hebron, Barcelona","STUDY_DIRECTOR",{"name":59,"affiliation":56,"role":60},"Jaume Capdevila, M.D.","STUDY_CHAIR",[62],{"name":63,"role":64,"phone":65,"phoneExt":48,"email":66},"Secretaria Técnica GETNE","CONTACT","+34 93 434 44 12","getne@mfar.net",[68],{"facility":69,"status":70,"city":71,"state":48,"zip":48,"country":72,"countryCode":73,"cosmosGeoPoint":74,"geoPoint":79,"contacts":80},"Hospital Universitari Vall d'Hebron","RECRUITING","Barcelona","Spain","ES",{"type":75,"coordinates":76},"Point",[77,78],2.15899,41.38879,{"lat":78,"lon":77},[81,84],{"name":82,"role":64,"phone":48,"phoneExt":48,"email":83},"A responsible person designated by the sponsor, M.D.","investigacion@mfar.net",{"name":85,"role":86,"phone":48,"phoneExt":48,"email":48},"Principal investigator selected by the sponsor, M.D.","PRINCIPAL_INVESTIGATOR",{"type":88,"investigatorFullName":48,"investigatorTitle":48,"investigatorAffiliation":48,"oldNameTitle":48,"oldOrganization":48},"SPONSOR","100344489",false,"NCT03765333","GETNE Registration of Thyroid Cancer","Descriptive Observational Epidemiological Study on the Characteristics of Thyroid Cancer in Patients Treated in Oncology Services of Spanish Centers: National Registry of Thyroid Cancer - Differentiated, Medullary and Anaplastic","Inclusion Criteria:\n\n* Patients older than 18 years with diagnosis of differentiated, medullary or anaplastic thyroid cancer confirmed by histopathology.\n* Patients who agree to participate and are able to understand the information sheet and sign the informed consent\n\nExclusion Criteria:\n\n* Patients under 18 years of age.\n* Patients with other types of thyroid cancer or whose histopathological diagnosis has not been confirmed.\n* Patients who do not have the relevant basic information to be included in the study, according to the criteria of the principal investigator.","ALL","18 Years",{"count":98,"type":99},20,"ESTIMATED","OBSERVATIONAL","An epidemiological, observational, multicenter, cross-sectional, retrospective study on patients ≥ 18 years visited in the oncology services of the participating centers with diagnosis of primary thyroid cancer.",[103],"Thyroid Cancer","2024-10-02",{"date":106,"type":107},"2024-10-03","ACTUAL",{"date":109,"type":107},"2019-05-28",{"date":111,"type":99},"2025-12",{"name":5,"class":6},1]